FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

172 letters match. Newest first.

  1. Shuzy Rock Inc.

    FDA warns Shuzy Rock Inc. of adulterated hand sanitizers made under insanitary conditions and found below labeled alcohol strength.

    High risk
  2. NatureLab Corp.

    FDA warned NatureLab Corp., a Carrollton, Texas dietary supplement maker, that its products are adulterated from CGMP violations and misbranded.

    Medium
  3. Advanced Cosmetic Research Laboratories Inc.

    FDA cited Advanced Cosmetic Research Laboratories for manufacturing-quality violations at its Chatsworth drug plant and an unapproved 5% lidocaine cream.

    High risk
  4. Med Pen Concepts, LLC

    FDA warned Med Pen Concepts about unapproved plasma skin devices and quality-system failures.

    High risk
  5. Nutritional Laboratories International, Inc. DBA Elite One Source Nutritional Services, Inc.

    FDA warns Nutritional Laboratories International over CGMP violations and misbranded dietary supplement labels found after 2021 inspection.

    Medium
  6. Oregon’s Wild Harvest, Inc.

    FDA warned Oregon's Wild Harvest after a September 2021 inspection found dietary supplement manufacturing violations: unproven identity and strength tests and foreign material in ingredients.

    High risk
  7. Deggeh Foods, Inc.

    FDA says Deggeh Foods sold supplement capsules and Moringa tea as unapproved drugs and violated manufacturing rules.

    High risk
  8. Muscle Feast, LLC

    Muscle Feast, LLC lacked ingredient identity and finished-product specifications for dietary supplements, FDA says.

    Medium
  9. DSP Skin Care LLC

    FDA cites DSP Skin Care for manufacturing failures and unapproved, misbranded Hongosan antifungal drugs.

    High risk
  10. Genlabs Corporation

    FDA warns Genlabs Corporation of Chino, California, that its OTC hand soaps are adulterated and misbranded after finding serious CGMP failures.

    High risk
  11. Monarch PCM, LLC

    Monarch PCM, LLC made unapproved skin drugs and broke manufacturing rules, with microbial contamination and weak investigations.

    High risk
  12. C R Supplements, LLC

    FDA warned C R Supplements that its mineral supplements were sold as unapproved new drugs and made without required quality controls.

    High risk
  13. Vitae Enim Vitae Scientific Inc.

    FDA warned Vitae Enim Vitae Scientific of sterile drug CGMP violations and contamination-control failures after a 2021 inspection, leading to a recall.

    High risk
  14. Princess Lifestyles, LLC

    FDA warns Princess Lifestyles over unapproved drug claims, CGMP failures, and ephedrine-alkaloid supplement Stomaisu.

    High risk
  15. Sunstar Americas, Inc.

    Sunstar Americas' water and quality failures led to contamination and recalls of oral rinses and dry-mouth devices.

    High risk
  16. Western Herb Products, Inc.

    FDA warned Western Herb Products over adulterated, misbranded Wormwood/Aloes capsules and serious dietary supplement manufacturing violations.

    Medium
  17. Chameleon Beverage Co. Inc. dba Chameleon Sanitizer Corporation

    FDA warned Chameleon Sanitizer Corporation that its hand sanitizer was made under insanitary conditions and violated manufacturing and misbranding rules.

    High risk
  18. Global Sanitizers LLC

    Global Sanitizers' hand sanitizers were adulterated with methanol substitution and had serious CGMP violations.

    High risk
  19. Nanomateriales Químicos Avanzados, S.A. de C.V.

    FDA found Mexican maker Nanomateriales' ZANILAST hand sanitizer labeled 65% ethanol contained 1-propanol, with quality and labeling violations.

    High risk
  20. Maison Terre, LLC

    FDA says Maison Terre repacked Goldenseal Root Powder under insanitary conditions with microbial contamination and sold unapproved drug products.

    High risk
  21. Allay Pharmaceuticals, LLC

    FDA warned Allay Pharmaceuticals over CGMP failures and sub-potent tablets, and distribution of an unapproved biological product.

    High risk
  22. Yuyao YiJia Daily Chemical Co., Ltd.

    Yuyao YiJia, a Chinese OTC drug and hand sanitizer maker, lacked finished-product, component and stability testing and an adequate quality unit.

    High risk